ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

New Frederick Contract Drops Slightly From ‘75

July 11, 1975

NTP Board Okays concept for New In Vitro study Using Oncogenes

May 10, 1985

AACR honors Five With Awards Next Month

April 2, 1993

Smoking Declines Among U.S. Teens, HHS Survey Finds.

January 18, 2002

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

May 28, 1976